The changes in transcript profile induced by vascular endothelial growth factor (VEGF-A) and serum withdrawal in primary human endometrial endothelial cells (ECs) were investigated using microarrays, gene ontology and pathway analysis. Vascular endothelial growth factor A altered the levels of transcripts involved in angiogenesis, cell survival, and apoptosis, including up-and downregulation of AKT1, BAD, MIF, and IGFBP3 and ANGPT2, respectively. Serum deprivation induced downregulation of cell-cycle-related transcripts such as mitosis regulators CDC20 and SPC25. Of the transcripts regulated by both VEGF-A and partial serum deprivation, remarkably 88 of 89 showed reciprocal regulation (p < 1 × 10 -49). These are predominantly cell-fate-associated transcripts and this novel observation suggests that endometrial ECs may be particularly dependant on the levels of these transcripts. Our results show that in addition to the known role of VEGF-A as an EC growth and survival promoter, it also regulates apoptosis-related messenger RNAs (mRNAs), many of which were reciprocally regulated following serum withdrawal.
Charnock-Jones DS, Sharkey AM, Rajput-Williams J., et al. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol Reprod. 1993;48(5):1120-1128.
2.
Smith SKRegulation of angiogenesis in the endometrium. Trends Endocrinol Metab. 2001;12(4):147-151.
3.
Smith OP, Critchley HOProgestogen only contraception and endometrial break through bleeding. Angiogenesis. 2005; 8(2):117-126.
4.
Reynolds LP, Grazul-Bilska AT, Redmer DAAngiogenesis in the female reproductive organs: pathological implications . Int J Exp Pathol. 2002;83(4):151-163.
5.
Moller B., Rasmussen C., Lindblom B., Olovsson M. Expression of the angiogenic growth factors VEGF, FGF-2, EGF and their receptors in normal human endometrium during the menstrual cycle. Mol Hum Reprod. 2001;7(1):65-72.
6.
Nor JE, Polverini PJRole of endothelial cell survival and death signals in angiogenesis. Angiogenesis. 1999;3(2):101-116.
7.
Girling JE, Rogers PARecent advances in endometrial angiogenesis research. Angiogenesis . 2005;8(2):89-99.
8.
Print C., Valtola R., Evans A., Lessan K., Malik S., Smith S.Soluble factors from human endometrium promote angiogenesis and regulate the endothelial cell transcriptome. Hum Reprod. 2004;19(10):2356-2366.
9.
Schatz F., Soderland C., Hendricks-Munoz KD, Gerrets RP, Lockwood CJHuman endometrial endothelial cells: isolation, characterization, and inflammatory-mediated expression of tissue factor and type 1 plasminogen activator inhibitor. Biol Reprod. 2000;62(3):691-697.
10.
Hewett PW, Murray JCImmunomagnetic purification of human microvessel endothelial cells using Dynabeads coated with monoclonal antibodies to PECAM-1. Eur J Cell Biol . 1993;62(2):451-454.
11.
Bredhult C. , Backlin BM, Olovsson M.Effects of some endocrine disruptors on the proliferation and viability of human endometrial endothelial cells in vitro . Reprod Toxicol. 2007;23(4):550-559.
12.
Campbell EA , O’Hara L., Catalano RD, Sharkey AM, Freeman TC, Johnson MHTemporal expression profiling of the uterine luminal epithelium of the pseudo-pregnant mouse suggests receptivity to the fertilized egg is associated with complex transcriptional changes. Hum Reprod. 2006; 21(10):2495-2513.
13.
Cheng CW, Bielby H., Licence D., Smith SK, Print CG, Charnock-Jones DSQuantitative cellular and molecular analysis of the effect of progesterone withdrawal in a murine model of decidualization. Biol Reprod . 2007;76(5):871-883.
14.
Rossi M., Sharkey AM, Vigano P., et al. Identification of genes regulated by interleukin-1beta in human endometrial stromal cells. Reproduction. 2005 ;130(5):721-729.
15.
Breitling R. , Armengaud P., Amtmann A., Herzyk P.Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments . FEBS Lett. 2004;573(1-3):83-92.
16.
Baldi P., Long ADA Bayesian framework for the analysis of microarray expression data: regularized t -test and statistical inferences of gene changes. Bioinformatics . 2001;17(6):509-519.
17.
Al-Shahrour F., Minguez P., Tarraga J., et al. BABELOMICS: a systems biology perspective in the functional annotation of genome-scale experiments. Nucleic Acids Res. 2006;34(Web Server issue):W472-W476.
18.
Hutchings G. , Gevaert T., Deprest J., et al. Immunohistochemistry using an antibody to unphosphorylated connexin 43 to identify human myometrial interstitial cells. Reprod Biol Endocrinol. 2008;6:43.
19.
Springhorn JP, Madri JA, Squinto SPHuman capillary endothelial cells from abdominal wall adipose tissue: isolation using an anti-pecam antibody. In Vitro Cell Dev Biol Anim. 1995;31(10):473-481.
20.
Lalor PF, Lai WK, Curbishley SM, Shetty S., Adams DHHuman hepatic sinusoidal endothelial cells can be distinguished by expression of phenotypic markers related to their specialised functions in vivo. World J Gastroenterol. 2006; 12(34):5429-5439.
21.
Iruela-Arispe ML, Rodriguez-Manzaneque JC, Abu-Jawdeh G.Endometrial endothelial cells express estrogen and progesterone receptors and exhibit a tissue specific response to angiogenic growth factors. Microcirculation. 1999;6(2):127-140.
22.
Au CL, Rogers PAImmunohistochemical staining of von Willebrand factor in human endometrium during normal menstrual cycle. Hum Reprod. 1993;8(1):17-23.
23.
Schoenfeld J., Lessan K., Johnson N., et al. Bioinformatic analysis of primary endothelial cell gene array data illustrated by the analysis of transcriptome changes in endothelial cells exposed to VEGF-A and PlGF. Angiogenesis. 2004;7(2): 143-156.
24.
Somanath PR, Razorenova OV, Chen J., Byzova TVAkt1 in endothelial cell and angiogenesis. Cell Cycle. 2006;5(5): 512-518.
25.
Chen J., Somanath PR, Razorenova O., et al. Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. Nat Med. 2005;11(11):1188-1196.
26.
Morales-Ruiz M., Fulton D., Sowa G., et al. Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt. Circ Res. 2000 ;86(8):892-896.
27.
Six I., Kureishi Y., Luo Z., Walsh K.Akt signaling mediates VEGF/VPF vascular permeability in vivo. FEBS Lett. 2002; 532(1-2):67-69.
28.
Gerber HP, McMurtrey A., Kowalski J., et al. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3’-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem . 1998;273(46):30336-30343.
29.
Gratton JP, Morales-Ruiz M., Kureishi Y., Fulton D., Walsh K., Sessa WCAkt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells. J Biol Chem. 2001;276(32):30359-30365.
30.
Datta SR, Dudek H., Tao X., et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 1997;91(2):231-241.
31.
Rusinol AE, Thewke D., Liu J., Freeman N., Panini SR, Sinensky MSAKT/protein kinase B regulation of BCL family members during oxysterol-induced apoptosis. J Biol Chem. 2004;279(2):1392-1399.
32.
Leber B., Lin J., Andrews DWEmbedded together: the life and death consequences of interaction of the Bcl-2 family with membranes. Apoptosis. 2007;12(5):897-911.
33.
Zha J., Harada H., Yang E., Jockel J., Korsmeyer SJSerine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell. 1996; 87(4):619-628.
34.
Gottlob K., Majewski N., Kennedy S., Kandel E., Robey RB, Hay N.Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev. 2001;15(11):1406-1418.
35.
Amin MA, Volpert OV, Woods JM, Kumar P., Harlow LA, Koch AEMigration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase. Circ Res. 2003;93(4):321-329.
36.
Lue H., Thiele M., Franz J., et al. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene. 2007;26(35):5046-5059.
37.
Ogawa H., Nishihira J., Sato Y., et al. An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis. Cytokine. 2000; 12(4):309-314.
38.
Gerritsen ME , Soriano R., Yang S., et al. Branching out: a molecular fingerprint of endothelial differentiation into tube-like structures generated by Affymetrix oligonucleotide arrays. Microcirculation. 2003;10(1):63-81.
39.
Gerritsen ME , Tomlinson JE, Zlot C., Ziman M., Hwang S.Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cells. Br J Pharmacol. 2003;140(4):595-610.
40.
Weston GC, Haviv I., Rogers PAMicroarray analysis of VEGF-responsive genes in myometrial endothelial cells . Mol Hum Reprod. 2002;8(9):855-863.
41.
Sadat S., Gehmert S., Song YH, et al. The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. Biochem Biophys Res Commun. 2007;363(3):674-679.
42.
Hellstrom A. , Perruzzi C., Ju M., et al. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A. 2001;98(10):5804-5808.
Franklin SL , Ferry RJ, Jr, Cohen P.Rapid insulin-like growth factor (IGF)-independent effects of IGF binding protein-3 on endothelial cell survival. J Clin Endocrinol Metab. 2003;88(2): 900-907.
45.
Oh SH, Kim WY, Kim JH, et al. Identification of insulin-like growth factor binding protein-3 as a farnesyl transferase inhibitor SCH66336-induced negative regulator of angiogenesis in head and neck squamous cell carcinoma. Clin Cancer Res. 2006;12(2):653-661.
46.
Liu B., Lee KW, Anzo M., et al. Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis. Oncogene . 2007;26(12): 1811-1819.
47.
Zhou J., Dsupin BA, Giudice LC, Bondy CAInsulin-like growth factor system gene expression in human endometrium during the menstrual cycle. J Clin Endocrinol Metab. 1994; 79(6):1723-1734.
48.
Fraser HM, Lunn SF, Kim H., et al. Changes in insulin-like growth factor-binding protein-3 messenger ribonucleic acid in endothelial cells of the human corpus luteum: a possible role in luteal development and rescue. J Clin Endocrinol Metab . 2000;85(4):1672-1677.
49.
Dahlfors G. , Arnqvist HJVascular endothelial growth factor and transforming growth factor-beta1 regulate the expression of insulin-like growth factor-binding protein-3, -4, and -5 in large vessel endothelial cells. Endocrinology. 2000;141(6):2062-2067.
50.
Fiedler U., Scharpfenecker M., Koidl S., et al. The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood. 2004; 103(11):4150-4156.
51.
Krikun G., Schatz F., Finlay T., et al. Expression of angiopoietin-2 by human endometrial endothelial cells: regulation by hypoxia and inflammation. Biochem Biophys Res Commun. 2000;275(1):159-163.
52.
Krikun G., Sakkas D., Schatz F., et al. Endometrial angiopoietin expression and modulation by thrombin and steroid hormones: a mechanism for abnormal angiogenesis following long-term progestin-only contraception. Am J Pathol. 2004; 164(6):2101-2107.
53.
Zhang L., Yang N., Park JW, et al. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Cancer Res. 2003;63(12):3403-3412.
54.
Sha G., Wu D., Zhang L., et al. Differentially expressed genes in human endometrial endothelial cells derived from eutopic endometrium of patients with endometriosis compared with those from patients without endometriosis. Hum Reprod . 2007;22(12):3159-3169.
55.
Bredhult C. , Sahlin L., Olovsson M. Gene expression analysis of human endometrial endothelial cells exposed to Bisphenol A. Reprod Toxicol.2009;28(1):18-25.
56.
Johnson NA, Sengupta S., Saidi SA, et al. Endothelial cells preparing to die by apoptosis initiate a program of transcriptome and glycome regulation. FASEB J. 2004;18(1): 188-190.
57.
Critchley HO , Brenner RM, Henderson TA, et al. Estrogen receptor beta, but not estrogen receptor alpha, is present in the vascular endothelium of the human and nonhuman primate endometrium. J Clin Endocrinol Metab. 2001;86(3): 1370-1378.
58.
Kayisli UA, Luk J., Guzeloglu-Kayisli O., Seval Y., Demir R., Arici A.Regulation of angiogenic activity of human endometrial endothelial cells in culture by ovarian steroids. J Clin Endocrinol Metab. 2004;89(11): 5794-5802.
59.
Krikun G., Schatz F., Taylor R., et al. Endometrial endothelial cell steroid receptor expression and steroid effects on gene expression. J Clin Endocrinol Metab . 2005;90(3): 1812-1818.
60.
Yasuo T., Kitaya K.Effect of ovarian steroids on gene expression profile in human uterine microvascular endothelial cells. Fertil Steril.2009;92(2):709-721.
